WELCOME TO ATTENDO AB (PUBL)'S ANNUAL GENERAL MEETING

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
WELCOME TO ATTENDO AB (PUBL)'S ANNUAL GENERAL MEETING

Attendo AB (publ) hereby gives notice of its Annual General Meeting to be held at 5:00 pm on Tuesday, 17 May 2016 at Viktor Rydbergs samskola, Viktor Rydbergs väg 2, Danderyd, Sweden. The convention hall opens for registration for the Annual General Meeting at 4:00 pm. Participation Shareholders are entitled to participate at the Annual General Meeting if they are entered in the share register maintained by Euroclear Sweden AB on Wednesday, 11 May 2016 and    have notified the company of their intention to participate by Wednesday, 11 May 2016 in one of the following ways: · on the website: www.attendo.com/annual-general-meeting-2016 · by telephone: 0771-24 64 00 · in writing to address: Computershare AB "Attendo AB's Annual General Meeting", Box 610, 182 16 Danderyd. The notification must include the shareholder's name, personal ID number or company registration number, address, telephone number and any assistants. Shareholders represented by proxy should submit proxy forms well in advance of the meeting. Personal data obtained from the share register maintained by Euroclear Sweden AB will be used for registration and preparing the voting register for the Annual General Meeting. Nominee-registered shares In order to be entitled to participate at the Annual General Meeting, shareholders whose shares are registered in the name of a nominee through a bank or other nominee must request that they are entered in the share register maintained by Euroclear Sweden AB on Wednesday, 11 May 2016. Shareholders should inform their nominees well in advance of this date. Proxies, etc. Shareholders who are represented by proxy must issue a proxy form for their proxy. If the proxy form has been issued by a legal entity, an attested copy of the certificate of registration of the legal entity evidencing its authority to issue the proxy form must be attached to the form. The original proxy form and the certificate of registration, where applicable, should be sent to Computershare AB "Attendo AB's Annual General Meeting" Box 610, 182 16 Danderyd, Sweden, well in advance of the Annual General Meeting. Proxy forms can be found on Attendo's website, www.attendo.com Right for shareholders to receive information Shareholders are reminded of their right to receive information from the Board of Directors and CEO at the Annual General Meeting in accordance with Chapter 7, section 32 of the Swedish Companies Act. Shareholders wishing to submit questions in advance may do so by sending a letter to Computershare AB "Attendo AB's Annual General Meeting" Box 610, 182 16 Danderyd, Sweden, or by email to: attendoboard@attendo.com Agenda 1. Election of the chairman of the Annual General Meeting. 2. Preparation and approval of the voting register. 3. Approval of the agenda. 4. Election of one or two persons to verify the minutes. 5. Determination of whether the meeting has been duly convened. 6. Presentation by the CEO. 7. Presentation of the parent company's annual report and auditor's report, as well as the consolidated financial statements and the auditor's report for the Attendo Group. 8. Resolutions to adopt the parent company's income statement and balance sheet, as well as the consolidated income statement and the consolidated balance sheet for the Attendo Group. 9. Resolutions to allocate the company's profit in accordance with the approved balance sheet and to determine a record date for dividends. 10. Resolution to discharge the Board Members and the CEO from liability. 11. Determination of: A. The number of Board Members to be appointed at the Annual General Meeting. B. The number of auditors and alternate auditors to be appointed at the Annual General Meeting. 12. Determination of: A. Fees to be paid to the Board Members. B. Fees to be paid to the auditors. 13. Election of the Chairman of the Board of Directors and other Board Members. 14. Election of auditors and alternate auditors. 15. Resolution to adopt guidelines for salaries and other remuneration for the CEO and other members of the Executive Management. 16. Resolution to adopt new instructions for the Nomination Committee. 17. Resolution regarding acquisitions and sales of the company's own shares. 18. Resolution to amend the articles of association. 19. Resolution to grant the Board of Directors the authority to issue new shares, whether applying or disapplying pre-emption rights for the company's shareholders. 20. Conclusion of the Annual General Meeting. Resolutions proposed by the Board of Directors Item 9 – Dividends and record date The Board of Directors proposes that a dividend of SEK 0.54 per share shall be paid to the shareholders and that Thursday, 19 May 2016 shall be the record date for receipt of the dividend. If the shareholders decide to adopt the proposal at the Annual General Meeting, the dividend is expected to be paid by Euroclear Sweden AB on Tuesday, 24 May 2016. Item 15 - Resolution to adopt guidelines for salaries and other remuneration for the CEO and other members of the Executive Management The Board of Directors proposes that guidelines for salaries and other remuneration for members of the company's Executive Management should entail that the remuneration is market-based to ensure that Attendo is able to attract and retain competent executives. The remuneration will be based on the individual's position, responsibilities and performance. The total remuneration package for members of the Executive Management comprises fixed salary, variable remuneration based on annual performance targets, long-term incentive programs and other benefits, such as non-monetary benefits, pensions and insurance. The remuneration package at Attendo will be competitive, but not market-leading. Item 17 – The Board of Directors' proposed resolution regarding acquisitions and sales of the company's own shares Authority to buy and sell the company's own shares The Board of Directors proposes that the shareholders adopt a resolution at the Annual General Meeting granting the Board of Directors the authority to buy and sell up to 400,000 shares in Attendo AB (publ) either on or outside Nasdaq Stockholm or pursuant to an offer to all of Attendo's shareholders. The authority may be exercised on one or more occasions up to the end of the Annual General Meeting 2017. Sales of the company's own shares The Board of Directors also proposes that the shareholders adopt a resolution at the Annual General Meeting regarding the allotment of shares in Attendo,which Attendo acquires by virtue of the authority proposed above, to participants in Attendo's share savings program (SSP 2015). The purpose of the above proposal and the reasons for disapplying shareholders' pre-emption rights is to ensure that the company's undertakings within the scope of Attendo’s SSP 2015, which was adopted at an extraordinary general meeting held in 2015, are met in a cost-effective manner. Item 18 – Resolution to amend the company's articles of association The Board of Directors proposes that the shareholders adopt a resolution at the Annual General Meeting 2016 to amend the company’s articles of association such that article 2 is amended in accordance with the underlined addition below. Proposed amended wording of article 2: 2. Registered office The registered office of the company shall be in the Municipality of Danderyd. General meetings may also be held in the Municipality of Stockholm. Item 19 – Authority for the Board of Directors to issue new shares The Board of Directors proposes that the shareholders adopt a resolution at the Annual General Meeting granting the Board of Directors the authority, on one or more occasions, for the period until the end of the next Annual General Meeting, to issue new shares, either applying or disapplying shareholders' pre-emption rights. The number of shares issued by virtue of the authority may not exceed an increase of ten (10) percent of the share capital based on the total share capital of the company on the date of the Annual General Meeting 2016. Resolutions proposed by the Nomination Committee Attendo AB (publ)'s Nomination Committee, which consists of chairman of the Nomination Committee Tomas Billing (Nordstjernan), Alireza Etemad (IK 2004 -fonden and its advisor IK Investment Partners), Marianne Nilsson (Swedbank Robur Fonder), Adam Nyström (Didner & Gerge Fonder) and Anssi Soila (Pertti Karjalainen), as well as Chairman of the Board of Directors Erik Lautmann (co -opted), who together represented approximately 60 percent of the voting rights in respect of all of the shares in the company as at 31 December 2015, proposes the following. Item 1 - Chairman of the Annual General Meeting Erik Lautmann is proposed as Chairman of the Annual General Meeting 2016. Item 11A - Number of Board Members The Nomination Committee proposes that the number of Board Members elected at the Annual General Meeting is increased from 8 to 10. Item 11B - Number of auditors and alternate auditors The Nomination Committee proposes that a registered auditing firm shall be appointed as auditor. Item 12A – Fees to the Board Members It is proposed that, as in the previous year, the following fees are paid to the Board of Directors and the auditor: · Chairman of the Board of Directors: SEK 700,000 · Other Board Members not employed by the company: SEK 300,000 Therefore, it is proposed that total fees amounting to SEK 3,100,000 are paid to the Board of Directors. It is proposed that, as in the previous year, the following fees are paid to the members of the committees of the Board of Directors: · Chairman of the Audit Committee: SEK 150,000 · Other members of the Audit Committee: SEK 75,000 · Chairman of the Compensation Committee: SEK 100,000 · Other members of the Compensation Committee: SEK 50,000 · Chairman of the Investment Committee: SEK 150,000 · Other members of the Investment Committee: SEK 75,000 Item 12B – Fees to the auditors It is proposed that fees are paid to the company's auditors upon approval of their invoices. Item 13 - Election of Board Members and the Chairman of the Board of Directors The Nomination Committee proposes that the following Board Members are elected for the period until the end of the next Annual General Meeting: It is proposed that Catarina Fagerholm, Tobias Lönnevall and Anitra Steen are newly-elected as Board Members, and that Erik Lautmann, Mona Boström, Jan Frykhammar, Ulf Lundahl, Anssi Soila, Christoffer Zilliacus and Henrik Borelius (CEO) are re-elected as Board Members. It is proposed that Erik Lautmann be re-elected as Chairman of the Board of Directors. Item 14 – Election of auditors It is proposed that PricewaterhouseCoopers AB are re-elected as auditor for the period until the end of the Annual General Meeting 2017. Subject to the approval by the shareholders of the Nomination Committee's proposal at the Annual General Meeting, PricewaterhouseCoopers AB has stated that the authorized public accountant Patrik Adolfson will continue as auditor in charge. Item 16 - Resolution to adopt revised instructions for the Nomination Committee The Nomination Committee proposes that a resolution shall be adopted to revise the company's instructions for the Nomination Committee, primarily comprising the cancellation of the specific instructions relating to the Annual General Meeting 2016 and the appointment of a new shareholder representative in the event of the occurrence of a significant change in ownership earlier than 31 January prior to the next Annual General Meeting. According to the proposal, the updated instructions for the Nomination Committee will apply until further notice. Other information Shares and voting rights Attendo's share capital amounts to SEK 876,951.445796 divided into 160,000,000 shares. All shares are of the same class and one (1) share entitles the holder to one (1) vote at general meetings. Majority rules The resolutions proposed by the Board of Directors in items 18 and 19 on the agenda will only be validly adopted if shareholders holding no less than two thirds of both the votes cast and the shares represented at the meeting vote in favour of the resolution. A resolution pursuant to item 17 on the agenda will only be validly adopted if shareholders holding no less than nine tenths of both the votes cast and the shares represented at the meeting vote in favour of the resolution. Further information Information about all of the individuals proposed as members of Attendo AB (publ)'s Board of Directors, information about the proposed auditor, the justified statements by the Nomination Committee regarding the proposed Board Members, and the Nomination Committee's complete proposals can be found on the company's website, www.attendo.com, and will be sent free of charge to shareholders who request the company to do so. Complete proposals and related documents regarding items 15, 16, 17, 18 and 19 on the agenda, concerning guidelines for salaries and other remuneration for members of the Executive Management, the adoption of new instructions for the Nomination Committee, acquisitions and sales of the company's own shares, amendments to the company's articles of association, and authority for the Board of Directors to issue new shares, will be made available by the company and on the company's website, www.attendo.com, and will be sent free of charge to shareholders who request the company to do so. Accounting documents and the auditor's report, auditor's statement regarding the application of guidelines for salaries and other remuneration, and the statement by the Board of Directors pursuant to Chapter 19, section 22 of the Swedish Companies Act, will be made available by the company and on the company's website, www.attendo.com, no later than on 26 April 2016, and will be sent free of charge to shareholders who request the company to do so. _______________ Stockholm, April 2016 Attendo AB (publ) The Board of Directors For further information, please contact: Ingalill Östman, Head of Investor Relations Attendo Phone: +46 708 67 42 12 E-mail: Ingalill.ostman@attendo.com Stefan Svanström, Communications Director Attendo Phone: +46 708 67 38 07 E-mail: stefan.svanstrom@attendo.com ________________________________________________________ Attendo - the leading care and healthcare company in the Nordics Attendo is the leading private provider of publicly financed care and healthcare services in the Nordic region. The company was founded in 1985 and was first to provide outsourced care for older people in Sweden. In addition to care for older people, Attendo provides care for people with disabilities, individuals and families, and, in Finland, healthcare and dental care. Attendo has 19 000 employees and is locally anchored with 510 operations in more than 200 municipalities in Sweden, Finland, Norway and Denmark. www.attendo.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berlin Heals Puts Microcurrent Therapy to a Real Test

Updated Category News Views 26

A silent electrical signal is heading into the sort of trial that separates intriguing ideas from credible medical evidence. Berlin Heals Holding AG has initiated C-MIC IV, an international randomized, double-blind, sham-controlled study of its implanted microcurrent therapy for symptomatic heart failure. The first patient has already been implanted in Kragujevac, Serbia....

Continue Reading
Modexus Opens a $500 Million Buyback With Real Caveats

Updated Category News Views 68

A half-billion-dollar buyback authorization can make a stock crowd sit up fast, and Modexus Solutions has plainly chosen that moment. On November 18, 2026, the Racine, Wisconsin-based thermal-management company said its board authorized repurchases of up to $500 million of common stock. For holders of NYSE:MOD, that is a meaningful declaration of intent. It says...

Continue Reading
LRM Adds Two IND Studies Testing Injectable PDGF in Skin

Updated Category News Views 9

Under-eye medicine has a nasty habit of outrunning the evidence, which makes LRM's decision to put injectable rhPDGF-BB through more formal study worth watching. Lynch Regenerative Medicine has announced two FDA-accepted INDs for investigator-initiated clinical trials: one examining what the material does inside facial skin, the other testing it for infraorbital...

Continue Reading
Docusign Pushes Contract Data Into ChatGPT Sales Tools

Updated Category News Views 187

Contracts are where sales momentum goes to get lost, buried under old PDFs, approval chains, and somebody’s half-finished CRM note. Docusign’s November 17, 2026 launch is a sensible attempt to drag that information into the place sellers may increasingly spend their working day: ChatGPT for Sales. The company’s new plugin lets a sales rep pull agreement intelligence...

Continue Reading
Perform.AI Tests Whether Stores Can Sell to Agents

Updated Category News Views 39

Shopping bots are about to become one more fussy customer standing in the aisle, except this one reads machine-facing files, rejects broken checkout steps, and does not care how pretty the homepage looks. Perform.AI has launched a free UCP and ACP Readiness Checker aimed at online retailers that need to know whether AI agents can find products, purchase them, and follow...

Continue Reading
Fidelis Puts $140,000 Behind Statewide Postpartum Care

Updated Category News Views 35

A missed postpartum appointment can look like a small administrative failure until it is not. Fidelis Care’s $140,000 round of Here for Your Health maternal health grants is aimed squarely at that unglamorous but consequential gap: keeping new mothers connected to care after delivery, particularly in underserved New York communities. Small Dollars, Very Specific...

Continue Reading
Aurora Innovation Faces Legal Probe After Stock Plunge

Updated Category News Views 182

Aurora's Troubles Draw Legal Scrutiny Looks like Aurora Innovation’s in the hot seat again, and not in a good way. When you see Kessler Topaz Meltzer & Check, LLP throwing their name into the mix, you know it’s getting serious. This legal eagle firm is poking around, seeing if Aurora stepped over the line with investors after their latest stumble—a production delay...

Continue Reading
Voranigo Follow-Up Deepens the Glioma Care Debate Today

Updated Category News Views 159

Brain-tumor progress rarely arrives with a clean victory lap, but the longer INDIGO readout gives clinicians and sector watchers something sturdier than a one-time headline. Servier presented extended Phase 3 results for VORANIGO, or vorasidenib, at the Society for Neuro-Oncology meeting in Philadelphia on November 14 and 15, 2026. The central message is durable benefit...

Continue Reading
Texas Restaurants Get a New Read on Customer Demand

Updated Category News Views 148

Texas restaurant owners are being handed a sharper flashlight, and frankly it is overdue. HundredX and the Texas Restaurant Association have launched a pilot that gives TRA members access to the HundredX Restaurant Insights Platform, aiming to bring customer and market intelligence to the independent operators and regional chains that usually cannot pay big-company prices...

Continue Reading
Knowles Expands Its Teacher Pipeline With 39 Fellows

Updated Category News Views 32

Thirty-Nine Teachers Is Not a Trivial Signal Thirty-nine new math and science teachers may not rattle public markets, but it says plenty about where the real strain sits in American education. The Knowles Teacher Initiative has named its 2026 Teaching Fellowship class, its largest ever, and the timing is dead serious: schools are still wrestling with recruiting and...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation into GoHealth, Inc. Sparks Investor Concerns

Updated Category News Views 354

GoHealth, Inc. Under Investigation for Alleged Securities Fraud Pomerantz LLP has initiated an investigation regarding potential claims involving investors of GoHealth, Inc. (NASDAQ: GOCO). This probe aims to determine whether the company and some of its executives have participated in misleading practices concerning their financial statements. The firm is reaching out to...

Continue Reading
Exploring the Features of the 2026 Toyota GR Corolla

Updated Category News Views 334

Unleashing the Adventure with the 2026 Toyota GR Corolla Get ready for an adventurous experience with the all-new 2026 Toyota GR Corolla. Engineered to perfection, this vehicle is equipped with the innovative GR-FOUR All-Wheel Drive System, making it a formidable companion whether you're racing on the track or maneuvering through rugged terrains. The GR Corolla is...

Continue Reading
Tandem Diabetes Care Boosts Sales Guidance After Q3 Success

Updated Category News Views 65

Tandem Diabetes Care Reports Impressive Q3 Financial Results Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading name in insulin delivery and diabetes management technology, has reported its financial accomplishments for the third quarter of 2024. Following an exceptional performance, the company has also increased its sales guidance for the upcoming fiscal year. Key...

Continue Reading
Green IT Services Growth: A Comprehensive Market Overview

Updated Category News Views 193

Green IT Services Market: A Dynamic Overview The evolution of technology is more than just a trend; it represents a paradigm shift towards sustainability. As organizations embrace digital transformation, the focus on Green IT services has rapidly gained importance. The latest analyses indicate that the Green IT Services market, valued at USD 18.8 billion in recent years,...

Continue Reading
Duke Energy's Response to Hurricane Helene's Aftermath

Updated Category News Views 558

Hurricane Helene Aftermath and Power Restoration Efforts Following the severe impact of Hurricane Helene, Duke Energy (NYSE: DUK) has made remarkable progress in restoring electrical services to over 2.16 million customers. Despite these extensive restoration efforts, around 334,000 customers are still without power, largely in Upstate South Carolina and the mountainous...

Continue Reading